Sleep Apnea Devices Market
Market Insights on Sleep Apnea Devices covering sales outlook, demand forecast & up-to-date key trends
Sleep Apnea Devices Market By Product (Therapeutics, Diagnostics), End Use (Home Care Settings & Individuals, Sleep Laboratories & Hospitals) & Region - Forecast 2022 - 2032
Sleep Apnea Devices Market Outlook (2022-2032)
[322 Pages Report] Global demand for sleep apnea devices is projected to register a CAGR of 7.8% during the forecast period, up from US$ 7 Bn in 2021 to reach a valuation of US$ 9.5 Bn by 2026. Emergence of new devices for sleep apnea such as pressure compensating sensors is predicted to skyrocket the overall sleep apnea market growth.
The market is supported by:
- Rising adoption of these devices in home care settings
- Campaigns like 'sleep awareness week,' various organizations and government agencies
- Supportive government initiatives across various countries
- Ongoing diversification in product portfolios
- Rapidly growing geriatric population suffering from sleep apnea
- Use of technology-enabled sleep apnea devices for both diagnostic and treatment purposes
- Outstanding customer and employee experience
- Revenue, profit growth and business model innovation
Demand for sleep apnea devices is expected to positively drive the market over the forecast period owing to the focus of extensive R&D by manufacturers to support the healthcare sector with the prominent offerings.
Through campaigns like 'sleep awareness week,' various organizations and government agencies are focusing on raising awareness and diagnosis rates among these patients, and the market has been expanding at a steady rate.
|
Attributes |
Details |
|
Sleep Apnea Devices Market CAGR (2022 – 2032) |
7.8% |
|
Sleep Apnea Devices Market (2026) |
US$ 9.5 Bn |
|
Sleep Apnea Devices Market Attraction |
Rising adoption of these devices in home care settings due to increased pressure on healthcare facilities to treat sleep disorders effectively without having to visit hospitals to boost market growth. |
Let us know your requirement to get
100% FREE customization
North America Takes the Demand for Sleep Apnea Devices to New Highs
North America dominated the sleep apnea devices market in 2020, accounting for 49.0% of total sales. The increasing incidence of respiratory illnesses is causing some sleeping disturbance, boosting the sleep apnea devices market.
Furthermore, rising awareness of sleep apnea, a big patient pool, and foreign manufacturers are expected to boost this region's sleep apnea devices market share. Some of the key participants present in North America are Philips Respironics; Somnetics International Inc.; and ResMed.
Moreover, strategic initiatives by key players have also fueled market growth. For instance, in October, 2021, AirAvant Medical introduced a new device called Bongo Rx for the treatment of obstructive sleep apnea (OSA). The device is touted as a continuous positive airway pressure (CPAP) alternative and is clinically proven to treat mild to moderate OSA symptoms.
Opportunities for Market Players
Manufacturers are working hard for research and development of innovative offerings to serve a large customer base and that will allow the sleep apnea devices market to grow. Hence, manufacturers are adopting strategies such as mergers & acquisitions to expand their global footprint and add disruptive packaging advancements to their product portfolio.
Further, a number of international market participants are entering into acquisitions and mergers and implementing new technology to increase commercial capacity to gain a major revenue share.
For instance, in August 2021, Connected sleep device maker ResMed released the AirSense 11, one of its latest CPAP machine iteration, which includes a host of new features to treat obstructive sleep apnea. The machine has many of the same specs as ResMed’s previous device, the AirSense 10, but also includes exclusive access to new features.
These include device set-up tutorials on the myAir patient engagement app, personalized care guidance and remote patient monitoring through the AirView platform.It comes equipped with algorithms that deliver breath-by-breath therapy adjustments and provide nightly breathing data, such as the number of time a user spends using CPAP therapy, the number of sleep apnea events per hour, mask leaks and the number of times the mask was removed. AirSense 11 can also make remote software updates.
“Emergence of new devices for sleep apnea such as pressure compensating sensors is predicted to skyrocket the overall sleep apnea market growth.”
Despite their high effectiveness, the action efficacy of machine for sleep apnea is limited in several cases due to the fact that they require precise and consistent use as well as constant medical supervision, and the same acts as one of the major factors confining sleep apnea devices market outlook.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystHow Strong is the Impact of COVID-19 on Sleep Apnea Devices Market?
The COVID-19 pandemic has a beneficial influence on the sleep apnea devices market. COVID-19 infection exacerbated the symptoms of sleep apnea sufferers. In addition, the demand for sleep apnea devices such as PAP devices, Facial interfaces, adaptive servo-ventilation systems, airway clearing systems, oxygen concentrators, and accessories has skyrocketed.
Due to the unexpected emergence of the COVID-19 pandemic, the sleep apnea devices market has grown dramatically. Companies encountered operational and logistical issues in the first quarter of 2020 as a result of statewide lockdowns.
However, the enormous influx of COVID-19 patients and the virus's negative influence on sleep apnea patients eventually led to an increase in demand for sleep apnea devices and the manufacturing of sleep apnea devices such as PAP devices, masks, and sleep ventilators.
Lockdowns in many countries encouraged the use of home sleep apnea testing (HSATs) over PSG instruments. During the pandemic, telemedicine and teleconsultations gained popularity, which aided the sleep apnea devices market's growth.
However, with the introduction of multiple COVID-19 vaccines, it is projected that the incidence of COVID-19 would progressively reduce, and the sleep apnea devices market will continue to develop at a normal rate over the next five years.
What Factors are Propelling the Sleep Apnea Devices Market Growth?
"The growing awareness of the negative consequences of untreated sleep apnea augurs well for the sleep apnea devices market future trends."
The rapidly growing geriatric population suffering from sleep apnea and related health conditions have increased the demand for sleep apnea devices, boosting the sleep apnea devices market trends.
The most common sleep-related breathing disorder, obstructive sleep apnea, is associated with a significant disease burden.
Through campaigns like 'sleep awareness week,' various organizations and government agencies are focusing on raising awareness and diagnosis rates among these patients. This is expected to fuel the sleep apnea devices market size even more.
What Factors Impede the Sleep Apnea Devices Market?
High CPCP machine price negatively affects the sleep apnea devices market around the globe.
Despite the rising prevalence of the disorder and sedentary lifestyle-related diseases around the world, certain factors are limiting the market's growth. One of them is the high CPAP machine cost.
For OSA treatment, PSG and CPAP machines are the best options. The infrastructure and reimbursement systems in developed countries are well-established.
However, developing countries have a poor reimbursement system and high patient out-of-pocket expenses.
This, combined with the low rate of medical coverage in these countries, is limiting the number of patients who can receive treatment there. The sleep apnea devices market growth is being stifled as a result of this.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Comparative Analysis of Adjacent Sleep Apnea Devices Market
Sleep Apnea Devices Market:
|
Attributes |
Sleep Apnea Devices Market |
|
CAGR (2022 - 2032) |
7.8% |
|
Market Value (2026) |
US$ 9.5 Bn |
|
Growth Factor |
Campaigns like 'sleep awareness week,' various organisations and government agencies are focusing on raising awareness and diagnosis rates among these patients. |
|
Opportunity |
Use of technology-enabled sleep apnea devices for both diagnostic and treatment purposes in a variety of sleep disorders is expected to peak in the coming years. |
|
Key Trends |
Players in the industry are concentrating their efforts on research and development in order to create innovative technologies. |
Sleep Disorder Market:
|
Attributes d> |
Sleep Disorder Market |
|
CAGR (2022 - 2032) |
6.2% |
|
Market Value (2026) |
US$ 19 Bn |
|
Growth Factor |
The availability of effective diagnosis and treatment for the disorder and increasing expenditure on healthcareis expected to fuel market growth. |
|
Opportunity |
Technological advances, such as the development of advanced sleep diagnostic and therapeutic devices, will drive the growth of the sleep disorder market. |
|
Key Trends |
The increasing number of new product launches, as well as the region's high penetration of key players, are driving up market demand. |
CPAP Devices Market:
|
Attributes |
CPAP Devices Market |
|
CAGR (2022 - 2032) |
9.3% |
|
Market Value (2026) |
US$ 5 Bn |
|
Growth Factor |
The rising prevalence of sleep apnea disorder worldwide as a result of obesity, rising cardiovascular disease, diabetes, and other such diseases. |
|
Opportunity |
Advances in technology, as well as a scarcity of ventilators during the COVID-19 pandemic, contribute to the adoption of CPAP devices. |
|
Key Trends |
Rising patient adherence for pressure devices around the world and improving healthcare infrastructure. |
Technological advancement is expected to propel the demand for sleep apnea devices during the forecast period.
Players in the industry are concentrating their efforts on research and development in order to create innovative technologies.
For example, ResMed introduced AirMini, the world's smallest PAP device that is linked to the AirView remote patient monitoring platform.
Patients can view their data on their phones thanks to this device. As a result, the commercialization of such advanced devices will hasten the sleep apnea devices market statistics in the coming years.
Similarly, recently introduced lightweight, portable CPAP machines combined with pressure compensating sensors that can compensate for altitude-related drops in atmospheric pressure, increasing the adoption of sleep apnea devices.
New devices for sleep apnea are becoming more popular as they provide patients with more options and flexibility. As a result, the use of technology-enabled sleep apnea devices for diagnostic and treatment purposes in various sleep disorders is expected to peak in the coming years.
What Challenges is the Sleep Apnea Devices Market Confronted With?
“Adherence to treatment, particularly with the CPAP, has always been a challenge for sleep apnea patients."
In the short term, this lack of adherence will be a major impediment to the sleep apnea devices adoption trends. However, in the long run, it will have little impact because manufacturers are focusing on making their products more technologically advanced and reducing the drawbacks associated with their adherence to sleep apnea treatment.
The lack of patient compliance to CPAP therapy is a stumbling block in the market's expansion. This is primarily because of a lack of affordability and comfort.
How is the Sleep Apnea Devices Market Segmented?
The sleep apnea devices market is divided into treatments and diagnostics. The pharmaceuticals sector dominated the sleep apnea devices market in 2021, with a sleep apnea devices market value of USD 4,311 million. The rising incidence of sleep disorders and the growing desire for innovative treatments in sleep apnea management is expected to promote the use of therapeutic sleep apnea devices.
Furthermore, significant research and development operations by leading sleep apnea devices market players are projected to result in breakthrough therapeutic devices that would benefit the sleep apnea devices market even more. Such technical developments are reducing the drawbacks of traditional equipment.
This makes them even more handy, efficient, and simple to use, with few adverse effects.
The sleep laboratories and hospitals sector held the greatest proportion of the sleep apnea devices market. The home care settings/individuals category is expected to increase at the fastest CAGR, owing to a rising desire for home sleep testing among patients and insurance companies, as well as a favorable reimbursement environment for home sleep testing.
The therapeutic devices category dominated the sleep apnea devices market. The therapeutic devices category led the sleep apnea devices market, accounting for 79.6% of the sleep apnea devices market revenue share.
Continuous positive airway pressure treatment (CPAP) employs a CPAP machine to assist a person suffering from obstructive sleep apnea (OSA) in breathing more comfortable while sleeping. A CPAP machine raises the pressure in your throat, preventing your airway from collapsing as you breathe in.
The sleep apnea devices market is divided into therapeutic and diagnostic devices. Therapeutic devices account for the majority of the sleep apnea devices market.
The rising pool of identified sleep apnea patients, increasing acceptance of sleep apnea treatment devices, and better reimbursement scenarios for these sleep apnea devices are driving the segment's greatest sleep apnea devices market share.
The sleep apnea devices market is dominated by sleep labs and hospitals. During the projection period, the home care settings/individuals sector is predicted to increase at the quickest rate.
Which Region is Performing Better in the Sleep Apnea Devices Market?
North America dominated the sleep apnea devices market in 2020, accounting for 49.0% of total sales. The increasing incidence of respiratory illnesses is causing some sleeping disturbance, boosting the sleep apnea devices market.
Furthermore, rising awareness of sleep apnea, a big patient pool, and foreign manufacturers are expected to boost this region's sleep apnea devices market share.
Furthermore, the number of therapeutic tests for establishing the presence of sleep apnea in the region is fast increasing, as many people are concerned about the health concerns associated with this illness.
However, the sleep apnea devices market in the Asia Pacific is expected to rise at a rapid pace over the forecast period. The Asia Pacific sleep apnea devices market is being driven by a growing elderly population and an increase in the prevalence of lifestyle illnesses.
According to the WHO, chronic respiratory illnesses, diabetes, cardiovascular diseases, and cancer are some of the top causes of mortality in the region.
According to the IDF Diabetes Atlas 9th Edition, about 87.6 million persons in the South East Asia area are diabetic, ranging in age from 20 to 79 years. With the incidence of chronic diseases on the rise, the area is projected to see an increase in the use of sleep apnea devices. According to a PubMed study, the prevalence of obstructive sleep apnea in middle-aged Asian men ranges from 4.1% to 7.5% and 2.1% to 3.2% in females.
According to an Asian Pacific Society of Respirology publication, the incidence of mild sleep apnea cases across APAC nations ranged from 7.8% in Hong Kong to 77.2% in Malaysia in May 2020.
Who are the Key Competitors in the Sleep Apnea Devices Market?
Key businesses like ResMed, Philips Respironics, and Somnetics International, Inc. have built a significant presence in the region as well as strong distribution networks to ensure a simple supply of their goods.
The fierce rivalry among sleep apnea devices market competitors to extend their regional footprints and increase their client pool through multiple product releases and new product innovations is expected to drive the sleep apnea devices market over the projected period.
For example, in February 2021, Nyxoah SA, the maker of the Obstructive Sleep Apnea (OSA) neurostimulator device, collaborated with Vanderbilt University to develop innovative neurostimulation options for OSA therapy.
Fisher & Paykel Healthcare introduced F&P Evora, a revolutionary nasal mask designed for obstructive sleep apnea (OSA) therapy. Furthermore, the integration of computer-assisted development and production will lead to new advancements in gadgets that allow for greater flexibility of movement while sleeping.
Itamar Medical has received FDA certification for its WatchPAT One, a single-use home sleep apnea test. These tests provide the highest level of precision and dependability for patients in-home care settings. Such product advancements are projected to increase the adoption of sleep apnea devices in-home care settings.
Key Segments
|
Attributes |
Details |
|
Forecast Period |
2022-2032 |
|
Historical Data Available for |
2015 – 2021 |
|
Market Analysis |
US$ Bn for Value |
|
By Product |
|
|
By End User |
|
|
By Region |
|
|
By Key Players |
|
Frequently Asked Questions
The sleep apnea devices market is likely to register a CAGR of 7.8% during 2022-2032.
The sleep apnea devices market value is projected to cross US$ 14.94 Bn by 2032.
The sleep apnea devices market size in 2021 was valued at US$ 7.1 Bn.
North America accounts for the largest revenue share in the sleep apnea devices market.
Europe is anticipated to grow at the highest CAGR in the sleep apnea devices market through 2032.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Fact.MR Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Demand
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background and Foundation Data Points
4.1. Global Market (US$ Mn)
4.2. Market Opportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Global Market Growth
4.5.3. Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Market Demand Analysis 2015-2021 and Forecast, 2022-2032
6.1. Historical Market Analysis, 2015-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Market Value Analysis 2015-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Product, 2015-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022-2032
8.3.1. Therapeutics
8.3.1.1. Airway Clearance Systems
8.3.1.2. Adaptive Servo-ventilation (ASV)
8.3.1.3. Positive Airway Pressure (PAP) Device
8.3.1.4. Oral Appliances
8.3.1.5. Oxygen Devices
8.3.1.6. Others
8.3.2. Diagnostics
8.3.2.1. Actigraphy Systems
8.3.2.2. Polysomnography (PSG) Device
8.3.2.3. Respiratory Polygraph
8.3.2.4. Sleep Screening Devices
8.4. Market Attractiveness Analysis By Product
9. Global Market Analysis 2015-2021 and Forecast 2022-2032, By End-use
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By End-use, 2015-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End-use, 2022-2032
9.3.1. Home Care Settings & Individuals
9.3.2. Sleep Laboratories & Hospitals
9.4. Market Attractiveness Analysis By End-use
10. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Region
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021
10.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. Asia Pacific
10.3.5. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2015-2021 and Forecast 2022-2032
11.1. Introduction
11.2. Pricing Analysis
11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
11.4.1. By Country
11.4.1.1. U.S.
11.4.1.2. Canada
11.4.1.3. Rest of North America
11.4.2. By Product
11.4.3. By End-use
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Product
11.5.3. By End-use
12. Latin America Market Analysis 2015-2021 and Forecast 2022-2032
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
12.4.1. By Country
12.4.1.1. Brazil
12.4.1.2. Mexico
12.4.1.3. Rest of Latin America
12.4.2. By Product
12.4.3. By End-use
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Product
12.5.3. By End-use
13. Europe Market Analysis 2015-2021 and Forecast 2022-2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
13.4.1. By Country
13.4.1.1. Germany
13.4.1.2. France
13.4.1.3. U.K.
13.4.1.4. Italy
13.4.1.5. Benelux
13.4.1.6. Nordic Countries
13.4.1.7. Rest of Europe
13.4.2. By Product
13.4.3. By End-use
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product
13.5.3. By End-use
14. Asia Pacific Market Analysis 2015-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. China
14.4.1.2. Japan
14.4.1.3. South Korea
14.4.1.4. Rest of Asia Pacific
14.4.2. By Product
14.4.3. By End-use
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product
14.5.3. By End-use
15. Middle East and Africa Market Analysis 2015-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
15.4.1. By Country
15.4.1.1. GCC Countries
15.4.1.2. South Africa
15.4.1.3. Turkey
15.4.1.4. Rest of Middle East and Africa
15.4.2. By Product
15.4.3. By End-use
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product
15.5.3. By End-use
16. Key Countries Market Analysis 2015-2021 and Forecast 2022-2032
16.1. Introduction
16.1.1. Market Value Proportion Analysis, By Key Countries
16.1.2. Global Vs. Country Growth Comparison
16.2. US Market Analysis
16.2.1. Value Proportion Analysis by Market Taxonomy
16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.2.2.1. By Product
16.2.2.2. By End-use
16.3. Canada Market Analysis
16.3.1. Value Proportion Analysis by Market Taxonomy
16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.3.2.1. By Product
16.3.2.2. By End-use
16.4. Mexico Market Analysis
16.4.1. Value Proportion Analysis by Market Taxonomy
16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.4.2.1. By Product
16.4.2.2. By End-use
16.5. Brazil Market Analysis
16.5.1. Value Proportion Analysis by Market Taxonomy
16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.5.2.1. By Product
16.5.2.2. By End-use
16.6. Germany Market Analysis
16.6.1. Value Proportion Analysis by Market Taxonomy
16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.6.2.1. By Product
16.6.2.2. By End-use
16.7. France Market Analysis
16.7.1. Value Proportion Analysis by Market Taxonomy
16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.7.2.1. By Product
16.7.2.2. By End-use
16.8. Italy Market Analysis
16.8.1. Value Proportion Analysis by Market Taxonomy
16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.8.2.1. By Product
16.8.2.2. By End-use
16.9. BENELUX Market Analysis
16.9.1. Value Proportion Analysis by Market Taxonomy
16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.9.2.1. By Product
16.9.2.2. By End-use
16.10. UK Market Analysis
16.10.1. Value Proportion Analysis by Market Taxonomy
16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.10.2.1. By Product
16.10.2.2. By End-use
16.11. Nordic Countries Market Analysis
16.11.1. Value Proportion Analysis by Market Taxonomy
16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.11.2.1. By Product
16.11.2.2. By End-use
16.12. China Market Analysis
16.12.1. Value Proportion Analysis by Market Taxonomy
16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.12.2.1. By Product
16.12.2.2. By End-use
16.13. Japan Market Analysis
16.13.1. Value Proportion Analysis by Market Taxonomy
16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.13.2.1. By Product
16.13.2.2. By End-use
16.14. South Korea Market Analysis
16.14.1. Value Proportion Analysis by Market Taxonomy
16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.14.2.1. By Product
16.14.2.2. By End-use
16.15. GCC Countries Market Analysis
16.15.1. Value Proportion Analysis by Market Taxonomy
16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.15.2.1. By Product
16.15.2.2. By End-use
16.16. South Africa Market Analysis
16.16.1. Value Proportion Analysis by Market Taxonomy
16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.16.2.1. By Product
16.16.2.2. By End-use
16.17. Turkey Market Analysis
16.17.1. Value Proportion Analysis by Market Taxonomy
16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
16.17.2.1. By Product
16.17.2.2. By End-use
16.17.3. Competition Landscape and Player Concentration in the Country
17. Market Structure Analysis
17.1. Market Analysis by Tier of Companies
17.2. Market Concentration
17.3. Market Share Analysis of Top Players
17.4. Market Presence Analysis
17.4.1. By Regional footprint of Players
17.4.2. Product footprint by Players
18. Competition Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Competition Deep Dive
18.3.1. BMC Medical Co., Ltd.
18.3.1.1. Overview
18.3.1.2. Product Portfolio
18.3.1.3. Sales Footprint
18.3.1.4. Strategy Overview
18.3.2. LivaNova PLC
18.3.2.1. Overview
18.3.2.2. Product Portfolio
18.3.2.3. Sales Footprint
18.3.2.4. Strategy Overview
18.3.3. Cadwell Laboratories Inc.
18.3.3.1. Overview
18.3.3.2. Product Portfolio
18.3.3.3. Sales Footprint
18.3.3.4. Strategy Overview
18.3.4. Fisher & Paykel Healthcare
18.3.4.1. Overview
18.3.4.2. Product Portfolio
18.3.4.3. Sales Footprint
18.3.4.4. Strategy Overview
18.3.5. Invacare Corporation
18.3.5.1. Overview
18.3.5.2. Product Portfolio
18.3.5.3. Sales Footprint
18.3.5.4. Strategy Overview
18.3.6. Itamar Medical Ltd
18.3.6.1. Overview
18.3.6.2. Product Portfolio
18.3.6.3. Sales Footprint
18.3.6.4. Strategy Overview
18.3.7. Natus Medical Inc.
18.3.7.1. Overview
18.3.7.2. Product Portfolio
18.3.7.3. Sales Footprint
18.3.7.4. Strategy Overview
18.3.8. Nihon Kohden
18.3.8.1. Overview
18.3.8.2. Product Portfolio
18.3.8.3. Sales Footprint
18.3.8.4. Strategy Overview
18.3.9. Koninklijke Philips N.V.
18.3.9.1. Overview
18.3.9.2. Product Portfolio
18.3.9.3. Sales Footprint
18.3.9.4. Strategy Overview
18.3.10. ResMed Inc.
18.3.10.1. Overview
18.3.10.2. Product Portfolio
18.3.10.3. Sales Footprint
18.3.10.4. Strategy Overview
18.3.11. Teleflex Inc.
18.3.11.1. Overview
18.3.11.2. Product Portfolio
18.3.11.3. Sales Footprint
18.3.11.4. Strategy Overview
18.3.12. Drive DeVilbiss International
18.3.12.1. Overview
18.3.12.2. Product Portfolio
18.3.12.3. Sales Footprint
18.3.12.4. Strategy Overview
19. Assumptions and Acronyms Used
20. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Market Value (US$ Mn), By Product, 2015 – 2021
Table 2: Global Market Value (US$ Mn), By Product, 2022 – 2032
Table 3: Global Market Value (US$ Mn), By End-use, 2015 – 2021
Table 4: Global Market Value (US$ Mn), By End-use, 2022 – 2032
Table 5: Global Market, By Region, 2015 – 2021
Table 6: Global Market, By Region, 2022 – 2032
Table 7: North America Market Value (US$ Mn), By Product, 2015 – 2021
Table 8: North America Market Value (US$ Mn), By Product, 2022 – 2032
Table 9: North America Market Value (US$ Mn), By End-use, 2015 – 2021
Table 10: North America Market Value (US$ Mn), By End-use, 2022 – 2032
Table 11: North America Market, By Country, 2015 – 2021
Table 12: North America Market, By Country, 2022 – 2032
Table 13: Latin America Market Value (US$ Mn), By Product, 2015 – 2021
Table 14: Latin America Market Value (US$ Mn), By Product, 2022 – 2032
Table 15: Latin America Market Value (US$ Mn), By End-use, 2015 – 2021
Table 16: Latin America Market Value (US$ Mn), By End-use, 2022 – 2032
Table 17: Latin America Market, By Country, 2015 – 2021
Table 18: Latin America Market, By Country, 2022 – 2032
Table 19: Europe Market Value (US$ Mn), By Product, 2015 – 2021
Table 20: Europe Market Value (US$ Mn), By Product, 2022 – 2032
Table 21: Europe Market Value (US$ Mn), By End-use, 2015 – 2021
Table 22: Europe Market Value (US$ Mn), By End-use, 2022 – 2032
Table 23: Europe Market, By Country, 2015 – 2021
Table 24: Europe Market, By Country, 2022 – 2032
Table 25: Asia Pacific Market Value (US$ Mn), By Product, 2015 – 2021
Table 26: Asia Pacific Market Value (US$ Mn), By Product, 2022 – 2032
Table 27: Asia Pacific Market Value (US$ Mn), By End-use, 2015 – 2021
Table 28: Asia Pacific Market Value (US$ Mn), By End-use, 2022 – 2032
Table 29: Asia Pacific Market, By Country, 2015 – 2021
Table 30: Asia Pacific Market, By Country, 2022 – 2032
Table 31: MEA Market Value (US$ Mn), By Product, 2015 – 2021
Table 32: MEA Market Value (US$ Mn), By Product, 2022 – 2032
Table 33: MEA Market Value (US$ Mn), By End-use, 2015 – 2021
Table 34: MEA Market Value (US$ Mn), By End-use, 2022 – 2032
Table 35: MEA Market, By Country, 2015 – 2021
Table 36: MEA Market, By Country, 2022 – 2032
Table 37: Global Market Incremental $ Opportunity, By Product, 2015 - 2021
Table 38: Global Market Incremental $ Opportunity, By End-use, 2022 – 2032
Table 39: Global Market Incremental $ Opportunity, By Region, 2022 – 2032
Table 40: North America Market Incremental $ Opportunity, By Product, 2015 - 2021
Table 41: North America Market Incremental $ Opportunity, By End-use, 2022 – 2032
Table 42: North America Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 43: Latin America Market Incremental $ Opportunity, By Product, 2015 - 2021
Table 44: Latin America Market Incremental $ Opportunity, By End-use, 2022 – 2032
Table 45: Latin America Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 46: Europe Market Incremental $ Opportunity, By Product, 2015 - 2021
Table 47: Europe Market Incremental $ Opportunity, By End-use, 2022 – 2032
Table 48: Europe Market Incremental $ Opportunity, By Country, 2022 - 2032
Table 49: Asia Pacific Market Incremental $ Opportunity, By Product, 2015 - 2021
Table 50: Asia Pacific Market Incremental $ Opportunity, By End-use, 2022 – 2032
Table 51: Asia Pacific Market Incremental $ Opportunity, By Country, 2022 – 2032
Table 52: MEA Market Incremental $ Opportunity, By Product, 2015 - 2021
Table 53: MEA Market Incremental $ Opportunity, By End-use, 2022 – 2032
Table 54: MEA Market Incremental $ Opportunity, By Country, 2022 - 2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 2: Global Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 3: Global Market Share, By Product, 2022 & 2032
Figure 4: Global Market Y-o-Y Growth Projections, By Product – 2022-2032
Figure 5: Global Market Attractiveness Index, By Product – 2022-2032
Figure 6: Global Market Share, By End-use, 2022 & 2032
Figure 7: Global Market Y-o-Y Growth Projections, By End-use – 2022-2032
Figure 8: Global Market Attractiveness Index, By End-use – 2022-2032
Figure 9: Global Market Share, By Region, 2022 & 2032
Figure 10: Global Market Y-o-Y Growth Projections, By Region – 2022-2032
Figure 11: Global Market Attractiveness Index, By Region – 2022-2032
Figure 12: North America Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 13: North America Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 14: North America Market Share, By Product, 2022 & 2032
Figure 15: North America Market Y-o-Y Growth Projections, By Product – 2022-2032
Figure 16: North America Market Attractiveness Index, By Product – 2022-2032
Figure 17: North America Market Share, By End-use, 2022 & 2032
Figure 18: North America Market Y-o-Y Growth Projections, By End-use – 2022-2032
Figure 19: North America Market Attractiveness Index, By End-use – 2022-2032
Figure 20: North America Market Share, By Country, 2022 & 2032
Figure 21: North America Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 22: North America Market Attractiveness Index, By Country – 2022-2032
Figure 23: Latin America Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 24: Latin America Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 25: Latin America Market Share, By Product, 2022 & 2032
Figure 26: Latin America Market Y-o-Y Growth Projections, By Product – 2022-2032
Figure 27: Latin America Market Attractiveness Index, By Product – 2022-2032
Figure 28: Latin America Market Share, By End-use, 2022 & 2032
Figure 29: Latin America Market Y-o-Y Growth Projections, By End-use – 2022-2032
Figure 30: Latin America Market Attractiveness Index, By End-use – 2022-2032
Figure 31: Latin America Market Share, By Country, 2022 & 2032
Figure 32: Latin America Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 33: Latin America Market Attractiveness Index, By Country – 2022-2032
Figure 34: Europe Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 35: Europe Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 36: Europe Market Share, By Product, 2022 & 2032
Figure 37: Europe Market Y-o-Y Growth Projections, By Product – 2022-2032
Figure 38: Europe Market Attractiveness Index, By Product – 2022-2032
Figure 39: Europe Market Share, By End-use, 2022 & 2032
Figure 40: Europe Market Y-o-Y Growth Projections, By End-use – 2022-2032
Figure 41: Europe Market Attractiveness Index, By End-use – 2022-2032
Figure 42: Europe Market Share, By Country, 2022 & 2032
Figure 43: Europe Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 44: Europe Market Attractiveness Index, By Country – 2022-2032
Figure 45: MEA Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 46: MEA Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 47: MEA Market Share, By Product, 2022 & 2032
Figure 48: MEA Market Y-o-Y Growth Projections, By Product – 2022-2032
Figure 49: MEA Market Attractiveness Index, By Product – 2022-2032
Figure 50: MEA Market Share, By End-use, 2022 & 2032
Figure 51: MEA Market Y-o-Y Growth Projections, By End-use – 2022-2032
Figure 52: MEA Market Attractiveness Index, By End-use – 2022-2032
Figure 53: MEA Market Share, By Country, 2022 & 2032
Figure 54: MEA Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 55: MEA Market Attractiveness Index, By Country – 2022-2032
Figure 56: Asia Pacific Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 57: Asia Pacific Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn
Figure 58: Asia Pacific Market Share, By Product, 2022 & 2032
Figure 59: Asia Pacific Market Y-o-Y Growth Projections, By Product – 2022-2032
Figure 60: Asia Pacific Market Attractiveness Index, By Product – 2022-2032
Figure 61: Asia Pacific Market Share, By End-use, 2022 & 2032
Figure 62: Asia Pacific Market Y-o-Y Growth Projections, By End-use – 2022-2032
Figure 63: Asia Pacific Market Attractiveness Index, By End-use – 2022-2032
Figure 64: Asia Pacific Market Share, By Country, 2022 & 2032
Figure 65: Asia Pacific Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 66: Asia Pacific Market Attractiveness Index, By Country – 2022-2032
Figure 67: US Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 68: US Market Share, By Product, 2021
Figure 69: US Market Share, By End-use, 2021
Figure 70: Canada Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 71: Canada Market Share, By Product, 2021
Figure 72: Canada Market Share, By End-use, 2021
Figure 73: Brazil Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 74: Brazil Market Share, By Product, 2021
Figure 75: Brazil Market Share, By End-use, 2021
Figure 76: Mexico Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 77: Mexico Market Share, By Product, 2021
Figure 78: Mexico Market Share, By End-use, 2021
Figure 79: Germany Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 80: Germany Market Share, By Product, 2021
Figure 81: Germany Market Share, By End-use, 2021
Figure 82: U.K. Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 83: U.K. Market Share, By Product, 2021
Figure 84: U.K. Market Share, By End-use, 2021
Figure 85: France Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 86: France Market Share, By Product, 2021
Figure 87: France Market Share, By End-use, 2021
Figure 88: Italy Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 89: Italy Market Share, By Product, 2021
Figure 90: Italy Market Share, By End-use, 2021
Figure 91: BENELUX Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 92: BENELUX Market Share, By Product, 2021
Figure 93: BENELUX Market Share, By End-use, 2021
Figure 94: Nordic Countries Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 95: Nordic Countries Market Share, By Product, 2021
Figure 96: Nordic Countries Market Share, By End-use, 2021
Figure 97: China Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 98: China Market Share, By Product, 2021
Figure 99: China Market Share, By End-use, 2021
Figure 100: Japan Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 101: Japan Market Share, By Product, 2021
Figure 102: Japan Market Share, By End-use, 2021
Figure 103: South Korea Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 104: South Korea Market Share, By Product, 2021
Figure 105: South Korea Market Share, By End-use, 2021
Figure 106: GCC Countries Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 107: GCC Countries Market Share, By Product, 2021
Figure 108: GCC Countries Market Share, By End-use, 2021
Figure 109: South Africa Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 110: South Africa Market Share, By Product, 2021
Figure 111: South Africa Market Share, By End-use, 2021
Figure 112: Turkey Market Value (US$ Mn) and Forecast, 2022 - 2032
Figure 113: Turkey Market Share, By Product, 2021
Figure 114: Turkey Market Share, By End-use, 2021
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
